[LRMR] YoY Quarter Result on 31-Dec-2020 [#Q4]

Stock
[LRMR] Larimar Therapeutics, Inc.
Announcement Date
04-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -38.24%
YoY- -133.76%
Quarter Report
LRMR's Result
LRMR's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -12,993 -9,425 -9,134 -14,203 -6,076 -14,570 -13,085 -0.11%
Tax 37 -1,014 -88 -50 -1,175 0 0 -
NP -12,993 -8,411 -9,134 -14,203 -6,076 -14,570 -13,085 -0.11%
Tax Rate - - - - - - - -
Total Cost 12,993 8,411 9,134 14,203 6,076 14,570 13,085 -0.11%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.30 -0.35 -0.50 -0.89 -0.66 -4.52 -4.77 -36.92%
EPS Diluted -0.30 -0.35 -0.50 -0.89 -0.66 -4.52 -4.77 -36.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.